Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients

Clinical trial NCT06457477 · UNKNOWN

Trial details

NCT number: NCT06457477
Sponsor: Beijing 302 Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2024-06-15
Primary completion: 2025-12-15
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.